Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/64407
Title: Study the regulatory role of angiotensin peptides in brown adipocyte differentiation
Authors: Li, Ru
Keywords: DRNTU::Engineering::Bioengineering
Issue Date: 2015
Abstract: Obesity, which is increased prevalence worldwide, is a kind of metabolic disorder that fats excessively accumulate in the body. Research has shown that obesity has become a primary global health problem, especially because obesity is strongly related with atherosclerosis, type II diabetes, and insulin resistance. The discovery of brown adipocytes and brite adipocytes in humans provide the potential to reduce obesity and hence prevent metabolic sequelae, especially diabetes and insulin resistance. However, the level of brown adipocytes is low in human adults, particularly in obese patients. Therefore, it is important to identify the regulatory pathways to stimulate the development of brown adipocyte. This research aims to explore and discover the relationship between renin-angiotensin system (RAS) which has been discovered as a crucial regulator of energy metabolism, and the “browning” process of BAT by using angiotensin. We studied the regulatory effect of exogenous Ang II and Ang (1-7). Besides, we also investigated the influences of Angotensin receptors. Overall, our results reveal exogenous application of Ang II has a positive effect on brown adipogenesis and it works mainly by AT2 receptor. This study may contribute the potential therapeutic target for obesity and related metabolic disorders.
URI: http://hdl.handle.net/10356/64407
Schools: School of Chemical and Biomedical Engineering 
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Theses

Files in This Item:
File Description SizeFormat 
LiRu15.pdf
  Restricted Access
2.18 MBAdobe PDFView/Open

Page view(s)

439
Updated on Mar 20, 2025

Download(s)

4
Updated on Mar 20, 2025

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.